Harmony Reynolds

Dr. Harmony Reynolds is Associate Professor of Medicine at the NYU Grossman School of Medicine, where she directs the Sarah Ross Soter Center for Women’s Cardiovascular Research and is associate director of the Cardiovascular Clinical Research Center. Dr. Reynolds’ research career has been focused on mechanisms and outcomes of cardiovascular disease in women and testing of treatment strategies for ischemic heart disease in clinical trials. She is particularly well known for her work in myocardial infarction with non-obstructive coronary arteries (MINOCA) and stable ischemic heart disease with nonobstructive coronary arteries (INOCA). Dr. Reynolds is the associate director of the clinical coordinating center (CCC) for the NHLBI-funded, international, multi-center ISCHEMIA trial. In addition, she was the principal investigator of the CIAO-ISCHEMIA study, an international, multi-center, NHLBI-funded study researching the relationship between changes in symptoms and changes in stress test results over time in patients with INOCA. She worked with colleagues to report on the relationship between medications and COVID-19 diagnosis and outcomes, and the role of microvascular and macrovascular thrombosis in severe or fatal COVID-19, leveraging extensive experience at the NYU Langone Health system in New York City, an early epicenter of the pandemic. She is co-principal investigator of the ACTIV-4 acute trial of anticoagulation in COVID-19 patients. Dr. Reynolds’ clinical efforts include general cardiology practice at NYU Langone Health, with a focus on cardiovascular disease in women, and supervision of fellows in the Bellevue Hospital cardiology clinic. She received her medical degree from NYU School of Medicine and completed her training in internal medicine and cardiology at NYU and Bellevue Hospital. She was named an AHA Founders Affiliate Rock Star of Research in 2011.